Invesco Biotechnology & Genome ETF
PBE
#1977
ETF rang
€0.39 Md
Capitalisation boursière
🇺🇸 US
Marché
89,89 €
Prix de l'action
-0.73%
Changement (1 jour)
33.60%
Changement (1 an)

Invesco Biotechnology & Genome ETF - Composition

Composition de l'ETF au 9 Novembre, 2026Nombre de participations : 33

Liste complète de la composition

Poids %NomSymboleActions détenues
5.64%
Biogen IncBIIB98122
5.56%
Gilead Sciences IncGILD145602
5.41%
Royalty Pharma PLCRPRX348978
5.39%
Regeneron Pharmaceuticals IncREGN25985
5.14%
Amgen IncAMGN48982
4.87%
Vertex Pharmaceuticals IncVRTX39180
4.79%
Illumina IncILMN96275
4.65%
Natera IncNTRA64333
4.51%
Moderna IncMRNA74391
3.60%
Vericel CorpVCEL273373
3.37%
Exelixis IncEXEL208311
3.09%
QIAGEN NVQGEN270680.3786
3.07%
Novavax IncNVAX1251603
3.05%
TG Therapeutics IncTGTX213194
3.04%
Legend Biotech CorpLEGN554702
2.99%
United Therapeutics CorpUTHR22787
2.93%
Neurocrine Biosciences IncNBIX77036
2.62%
Repligen CorpRGEN65029
2.51%
Halozyme Therapeutics IncHALO108078
2.50%
Incyte CorpINCY91080
2.43%
Sarepta Therapeutics IncSRPT624483
2.40%
Protagonist Therapeutics IncPTGX78460
2.40%
Collegium Pharmaceutical IncCOLL430111
2.36%
PTC Therapeutics IncPTCT160815
2.30%
BioMarin Pharmaceutical IncBMRN178692
2.19%
AnaptysBio IncANAB202417
2.07%
BioCryst Pharmaceuticals IncBCRX1201947
2.07%
Ardelyx IncARDX3125696
1.57%
Veracyte IncVCYT268281
1.44%
ACADIA Pharmaceuticals IncACAD386493
0.04%
Invesco Government & Agency PortfolioAGPXX158754.08
0.00%
CASH & EQUIVALENTSUSD5728
0.00%
USD Pending DividendsUSDPDV0